|
Recurrent GBM Treated With Neurosurgical Resection and IORT Using the Xoft Axxent eBx System and Bevacizumab (IORT)
NCT ID : 04681677
Protocol Number : JWC_CTPR-0017 GLIOX
Phase : IV
Location : Santa Monica, Ca
|
Naveed Wagle, M.D.
|
|
Pivotal, Randomized, Open-label Study of Optune® (Tumor Treating Fields) Concomitant With RT & TMZ for the Treatment of Newly Diagnosed GBM (EF-32)
NCT ID : NCT04471844
Protocol Number : TRIDENT EF-32
Phase : N/A
Location : Saint John's Cancer Institute
|
Santosh Kesari, M.D.
|
|
A Study of Berubicin in Adult Subjects With Recurrent Glioblastoma Multiforme
NCT ID : NCT04762069
Protocol Number : CNS-201
Phase : 2
Location : Saint John's Cancer Institute
|
Santosh Kesari, M.D.
|
|
Neurosurgical evaluation of a mobile CT scanner Clinical Protocol
NCT ID : N/A
Protocol Number : xCAT IQ
Phase : N/A
Location : Santa Monica, CA
|
Chester Griffiths, M.D.
|
|
Caris Biorepository Research Protocol
NCT ID : 01499394
Protocol Number : TCBIO-001-0710
Phase : N/A
Location : Santa Monica, CA
|
Santosh Kesari, M.D.
|
|
Synuclein-One Study
NCT ID : 04700722
Protocol Number : JWC_Synuclein
Phase : N/A
Location : Santa Monica, CA
|
Melita Petrossian, M.D.
|
|
Allogeneic Human Mesenchymal Stem Cells for Alzheimer’s Disease
NCT ID : 02833792
Protocol Number : STEM105-M-AD
Phase : 2
Location : Santa Monica, CA
|
Santosh Kesari, M.D.
|
|
An Open-label, Nonrandomized, Phase 1 Drug-Drug Interaction Study to Evaluate the Pharmacokinetics of Belinostat in Combination with Atazanavir in Patients with Advanced Relapsed/Refractory Solid Tumors or Hematological Malignancies
NCT ID : N/A
Protocol Number : SPI-BEL-107
Phase : 1
Location : Santa Monica, CA
|
Santosh Kesari, M.D.
|
|
The PREVENTION Trial: Precision Recommendations to Optimize Neurocognition (PREVENTION)
NCT ID : 04082611
Protocol Number : Prevention
Phase : N/A
Location : Santa Monica, CA
|
David Merrill, M.D.
|
|
Pilot Trial of Visual Healing® in Psilocybin-assisted Therapy for Alcohol Use Disorder
NCT ID : 04410913
Protocol Number : PTRIP002
Phase : 2
Location : Santa Monica, CA
|
Keith Heinzerling, M.D.
|
|
Intermediate-size Expanded Access to ONC201 for Patients with H3 K27M-mutant and/or Midline Gliomas
NCT ID : 04617002
Protocol Number : Oncoceutics_ONC028
Phase : Expanded Access
Location : Santa Monica, CA
|
Akanksha Sharma, MD
|
|
Open-label Study Investigating of OKN-007 Combined With Temozolomide in Patients With Recurrent Glioblastoma
NCT ID : 04388475
Protocol Number : OKN-007
Phase : 2
Location : Santa Monica, CA
|
Santosh Kesari, M.D.
|
|
mSIM: Mobile Simultaneous Aerobic Exercise and Memory Training Intervention for Older Adults With Amnestic Mild Cognitive Impairment (mSIM)
NCT ID : 04185298
Protocol Number : MSIM
Phase : N/A
Location : Santa Monica, CA
|
Sarah McEwen
|
|
A Longitudinal Assessment of Tumor Evolution in Patients With Brain Cancer
NCT ID : 03425292
Protocol Number : JWCI-17-0801
Phase : N/A
Location : Santa Monica, CA
|
Santosh Kesari, M.D.
|
|
A First in Human Study of AdAPT-001 in Subjects With Refractory Solid Tumors (BETA-PRIME)
NCT ID : 04673942
Protocol Number : BETA PRIME
Phase : 1
Location : Santa Monica, CA
|
Santosh Kesari, M.D.
|
|
A Retrospective Study Observational Study for H3 K27M-nutenat and/or Midline Gliomas
NCT ID : N/A
Protocol Number : ONC019
Phase : N/A
Location : Santa Monica, CA
|
Akanksha Sharma, M.D.
|
|
A Study of the Efficacy and Safety of Relacorilant in Patients With Endogenous Cushing Syndrome (GRACE)
NCT ID : 03697109
Protocol Number : CORT125134-455
Phase : 3
Location : Santa Monica, CA
|
Garni Barkhoudarian, M.D.
|
|
Pemetrexed for the Treatment of Chordoma
NCT ID : 03955042
Protocol Number : JWCI-18-0704
Phase : 1
Location : Santa Monica, CA
|
Santosh Kesari, M.D.
|
|
Memantine XR and Pregabalin for Chemotherapy-Induced Peripheral Neuropathy
NCT ID : 03709888
Protocol Number : JWCI-17-0101
Location : Santa Monica, CA
|
Santosh Kesari, M.D.
|
|
Overactive Bladder Treatment Using StimRouter Neuromodulation System: A Prospective Randomized Trial
NCT ID : 02873312
Protocol Number : CP-STMR-OAB-002
Location : Santa Monica, CA
|
Jean-Phillip Langevin, M.D.
|
|
Optune Delivered Electric Field Therapy and Bevacizumab in Treating Patients With Recurrent or Progressive Grade 2 or 3 Meningioma
NCT ID : 02847559
Protocol Number : NU 16C02
Phase : 2
Location : Santa Monica, CA
|
Santosh Kesari, M.D.
|
